LY6D and neoplasm: Mechanically, AP-1 and TGF-ß cooperativity drive the nuclear myocardin-related transcription factor (nMRTF) resistance pathway, which amplifies non-canonical GLI1 activity in the LY6D+ resistant tumor cells (54).